SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-008542
Filing Date
2020-04-28
Accepted
2020-04-28 16:09:21
Documents
1
Period of Report
2020-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3443
  Complete submission text file 0001567619-20-008542.txt   5014
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARIAD PHARMACEUTICALS 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Schlesinger Sarah J. (Reporting) CIK: 0001579873 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 20825065